Table 1 Demographics and clinical characteristics of the patients in each group.

From: Safety and efficacy of supraciliary dexamethasone implantation for macular oedema: a preliminary comparative study

Groups

Supraciliary

Intravitreal

Age

58 (31–79)

62 (36-79)

Lens status

 Phakic

10

8

 Pseudophakic

9

11

Sex

 F

10

13

 M

9

6

Indications

 DMO

10

12

 BRVO

1

3

 CRVO

1

2

 UCMO

5

2

 PCMO

2

1

Number of patients with capsule-lens compromise

1 (SFIOL)

1 (laser capsulotomy)

  1. BRVO branch retinal vein occlusion, CRVO central retinal vein occlusion, DMO diabetic macular oedema, F female, M male, PCMO pseudophakic cystoid macular oedema, SFIOL scleral fixated intraocular lens, UCMO uveitic cystoid macular oedema.
Back to article page